Novo Nordisk stock at DKK 252.45 on September 28, 2026
Published on 09/28/2026 at 19:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo Nordisk stock last traded at DKK 252.45 on September 28, 2026, at 2:20:30 p.m. CET on Nasdaq Copenhagen. The share was down DKK 0.55, or 0.21 percent, from the previous close.
Trading session
The quoted instrument is Novo Nordisk’s B share, listed on Nasdaq Copenhagen under Novo-B. The session data records the share at DKK 252.45 at the stated time.
Capital Markets Day ambitions
At its September 21, 2026, Capital Markets Day, Novo Nordisk outlined strategic ambitions for 2030. The company said it aims to launch more than five multi-blockbusters by 2030, deliver more than DKK 150 billion in risk-adjusted pipeline sales in 2035, scale capacity to serve 10 times more people with obesity using oral GLP-1 treatments, and serve more than 60 million patients globally by 2030. The release states that these ambitions are not financial outlook or guidance.
EASD 2026 presentations
In a September 16, 2026, release, Novo Nordisk said it will present 44 abstracts at the European Association for the Study of Diabetes 2026 meeting in Milan from September 28 through October 2. The presentations include data involving Wegovy, Ozempic, CagriSema and zenagamtide, covering obesity, diabetes and related cardiometabolic conditions.
